Trials / Completed
CompletedNCT01456897
A Long-term Trial of OPC-34712 in Patients With Schizophrenia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 282 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the safety and efficacy of long-term administration of OPC-34712 in patients with schizophrenia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPC-34712 | orally administered once daily |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2015-05-01
- First posted
- 2011-10-21
- Last updated
- 2019-12-30
- Results posted
- 2019-12-30
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01456897. Inclusion in this directory is not an endorsement.